US$ 27.49
glp 1 drugs hims semaglutide This week, pharmaceutical startup Hims & Hers Health launched an initiative to offer Novo Nordisk Abruptly Ends Partnership
Description
For context, cash prices for Wegovy and Zepbound typically run between $1,000 and $1,400 per month

GLP-1s, originally developed for metabolic disease, are now being investigated for their broader effects on biological systems relevant to aging
Essential demographic data included age, sex, and ethnicity, as well as existing comorbidities and medication usage
The biggest update is that several Indian pharmaceutical companies have already launched semaglutide products after patent expiry

Diabetes Care 32, 762768
Axelsen M, Sidhu S
